Suraksha Diagnostic Q2 FY27 PAT Up 69%, EBITDA Up 45%

Suraksha Diagnostic Limited announced its unaudited financial results for the quarter and half-year ended September 30, 2026. The company reported a strong performance with Profit After Tax (PAT) growing by 69% year-on-year to ₹149.50 million in Q2 FY27, and EBITDA increasing by 45% year-on-year to ₹363.17 million in the same period. For the half-year ended H1 FY27, Total Income grew by 24% to ₹1,893.09 million, EBITDA rose by 37% to ₹678.47 million, and PAT increased by 54% to ₹277.96 million. The company also expanded its network by opening five new centers and highlighted the growing potential of its genomics business.